Varian Medical Systems
Financials
Estimates*
| USD | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | - | 2.6b | 2.9b | 3.2b | 3.2b | 3.5b | 3.9b |
| % growth | - | - | 11 % | 10 % | (2 %) | 12 % | 10 % |
| EBITDA | - | 423m | 567m | 579m | 520m | 724m | 844m |
| % EBITDA margin | - | 16 % | 19 % | 18 % | 16 % | 20 % | 22 % |
| Profit | - | 219m | 150m | 292m | 269m | 446m | 529m |
| % profit margin | - | 8 % | 5 % | 9 % | 8 % | 13 % | 14 % |
| EV / revenue | - | 3.5x | 3.5x | 3.1x | 4.8x | - | - |
| EV / EBITDA | - | 21.7x | 18.3x | 17.6x | 29.6x | - | - |
| R&D budget | 264m | 193m | 224m | 242m | - | - | - |
| R&D % of revenue | - | 7 % | 8 % | 8 % | - | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Spinout | ||
| N/A | N/A | IPO | |
$16.4b Valuation: $16.4b 5.1x EV/LTM Revenues 28.3x EV/LTM EBITDA | Acquisition | ||
| Total Funding | - | ||
Related Content
Recent News about Varian Medical Systems
EditVarian, a Siemens Healthineers company, is at the forefront of revolutionizing cancer treatment through its Intelligent Cancer Care solutions. The company specializes in providing advanced oncology solutions that integrate software, machines, patient data, and care teams to create a unified approach to cancer treatment. Varian's mission is to eliminate the fear of cancer by combining human ingenuity with the power of data and technology.
Varian serves a diverse range of clients, primarily healthcare providers such as hospitals, cancer treatment centers, and healthcare systems. One notable client is CHRISTUS Health, a not-for-profit health system in the USA, which has benefited from Varian's technology to enhance the quality and efficiency of its cancer treatment services.
Operating in the oncology market, Varian focuses on developing and delivering cutting-edge radiation oncology services. The company offers a variety of products and services, including advanced software for treatment planning, radiation therapy machines, and data management systems. These solutions help healthcare providers deliver precise and effective cancer treatments, improving patient outcomes.
Varian's business model is centered around selling its technology and services to healthcare providers. The company generates revenue through the sale of its machines and software, as well as through ongoing service contracts and partnerships. For instance, its Oncology-as-a-Service (OaaS) offering provides a comprehensive, tech-enabled radiation oncology service, allowing healthcare providers to adopt advanced cancer treatment technologies without significant upfront investment.
In summary, Varian is a key player in the oncology market, offering innovative solutions that enhance cancer treatment through the integration of technology and data. Its business model focuses on selling advanced oncology products and services to healthcare providers, generating revenue through sales and service contracts.
Keywords: oncology, cancer treatment, radiation therapy, healthcare technology, patient data, software, machines, healthcare providers, advanced solutions, Siemens Healthineers.
Tech stack
Investments by Varian Medical Systems
Edit
